Semaglutide Drugs Show Promise in Helping to Keep Alzheimer’s Disease at Bay
Recent research suggests that semaglutide, a medication primarily used to treat type 2 diabetes and obesity, may have potential benefits in reducing the risk of Alzheimer’s disease. This groundbreaking discovery opens new avenues for treatment and prevention strategies in the fight against cognitive decline and neurodegenerative diseases. Understanding Semaglutide Semaglutide is a glucagon-like peptide-1 (GLP-1)… Read More: Semaglutide Drugs Show Promise in Helping to Keep Alzheimer’s Disease… »
